Plandai Biotechnology, Inc. Receives First Purchase Order in Exclusive Supplier Agreement With USN
13 mai 2015 09h00 HE
|
Plandai Biotechnology, Inc.
LOGAN, UT--(Marketwired - May 13, 2015) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) (“Plandaí” or “the Company”), producer of the highly bioavailable Phytofare® catechin complex, today announced that...
New Video Documents Plandai Biotechnology's $20 Million Operation at Senteeko Tea Estate
14 avr. 2015 08h30 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - April 14, 2015) - Plandaí Biotechnology (OTCQB: PLPL) and its operations at the Senteeko tea estate in South Africa are the subject of a newly released video. Stock...
Plandai Biotechnology Revives Senteeko Tea Estate Into Something to Be Appreciated
16 mars 2015 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - March 16, 2015) - Prior to heading to South Africa in an effort to document Plandaí Biotechnology's (OTCQB: PLPL) operations there, the only images we at Stock Market...
Plandai Biotechnology, Inc. Secures Collaboration Agreement to Further Company's Cannabis Research in Uruguay
26 janv. 2015 09h00 HE
|
Plandai Biotechnology, Inc.
LOGAN, UT--(Marketwired - January 26, 2015) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"), a developer of highly bioavailable plant extracts for industries including health,...
Plandai Biotechnology's Green Tea Extract Delivers Favorable Preliminary Results in Human Clinical Trial Conducted in South Africa
10 sept. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Sep 10, 2014) - Plandaí Biotechnology (OTCQB: PLPL) recently released the preliminary results from its human clinical trial where the company's green tea...
Plandai's Medical Marijuana Research Could Benefit From FDA Approval of Clinical Trials
26 nov. 2013 08h30 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Nov 26, 2013) - Plandaí Biotechnology (OTCQB: PLPL) timed its move into medical marijuana research perfectly. This month the U.S. Food and Drug Administration...
Plandai Biotechnology Enters Medical Marijuana Arena With Industry-Changing Technology
31 oct. 2013 08h30 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 31, 2013) - Plandaí Biotechnolgy, Inc. (OTCQB: PLPL) announced this week that it has entered the medical marijuana industry with its new wholly-owned...
Plandai Biotechnology, Inc. Enters Fourth Quarter Stronger Than Ever With Pheroid(TM) Technology
02 oct. 2013 08h45 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 2, 2013) - Plandaí Biotechnology Inc. (OTCQB: PLPL) already has a technology in place that is allowing it to boast of higher bioavailability with its...
Plandai Biotechnology, Inc. Announces Commencement of Clinical Trials Using Phytofare Topical Product
05 sept. 2013 09h00 HE
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Sep 5, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Plandai Biotechnology, Inc.'s Phytofare Could Address Growing Diabetes Numbers
04 sept. 2013 13h53 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Sep 4, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) is already hard at work in Africa to develop a treatment for malaria, and it may just have a product in its...